180 related articles for article (PubMed ID: 37527237)
1. Invitation methods for Indigenous New Zealand Māori in lung cancer screening: Protocol for a pragmatic cluster randomized controlled trial.
Parker K; Colhoun S; Bartholomew K; Sandiford P; Lewis C; Milne D; McKeage M; McKree Jansen R; Fong KM; Marshall H; Tammemägi M; Rankin NM; Hotu S; Young R; Hopkins R; Walker N; Brown R; Crengle S
PLoS One; 2023; 18(8):e0281420. PubMed ID: 37527237
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis.
McLeod M; Sandiford P; Kvizhinadze G; Bartholomew K; Crengle S
BMJ Open; 2020 Sep; 10(9):e037145. PubMed ID: 32973060
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
5. Perspectives of potentially eligible Indigenous Māori on a lung cancer screening programme: a qualitative study.
Colhoun SR; Parker K; McCook S; Bartholomew K; Baty B; Maxwell A; Pipi K; Marama M; Crengle S
N Z Med J; 2024 Apr; 137(1593):45-55. PubMed ID: 38603786
[TBL] [Abstract][Full Text] [Related]
6. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
[TBL] [Abstract][Full Text] [Related]
8. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.
Quaife SL; Ruparel M; Beeken RJ; McEwen A; Isitt J; Nolan G; Sennett K; Baldwin DR; Duffy SW; Janes SM; Wardle J
BMC Cancer; 2016 Apr; 16():281. PubMed ID: 27098676
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand.
Brewer N; Bartholomew K; Grant J; Maxwell A; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Foliaki S; Cunningham C; Douwes J; Potter JD
Lancet Reg Health West Pac; 2021 Nov; 16():100265. PubMed ID: 34590066
[TBL] [Abstract][Full Text] [Related]
10. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.
Crosbie PA; Gabe R; Simmonds I; Kennedy M; Rogerson S; Ahmed N; Baldwin DR; Booton R; Cochrane A; Darby M; Franks K; Hinde S; Janes SM; Macleod U; Messenger M; Moller H; Murray RL; Neal RD; Quaife SL; Sculpher M; Tharmanathan P; Torgerson D; Callister ME
BMJ Open; 2020 Sep; 10(9):e037075. PubMed ID: 32912947
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Indigenous primary health care models of service delivery: a scoping review protocol.
Harfield S; Davy C; Kite E; McArthur A; Munn Z; Brown N; Brown A
JBI Database System Rev Implement Rep; 2015 Nov; 13(11):43-51. PubMed ID: 26657463
[TBL] [Abstract][Full Text] [Related]
14. Examining the impact of COVID-19 on Māori:non-Māori health inequities in Aotearoa, New Zealand: an observational study protocol.
Curtis E; Jaung R; Paine SJ; McLeod M; Tamatea J; Atkinson J; Jiang Y; Robson B; Reid P; Harris RB
BMJ Open; 2024 Mar; 14(3):e083564. PubMed ID: 38458794
[TBL] [Abstract][Full Text] [Related]
15. Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: A community-based cluster randomised controlled trial.
MacDonald EJ; Geller S; Sibanda N; Stevenson K; Denmead L; Adcock A; Cram F; Hibma M; Sykes P; Lawton B
Aust N Z J Obstet Gynaecol; 2021 Feb; 61(1):135-141. PubMed ID: 33350455
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
Jaine R; Kvizhinadze G; Nair N; Blakely T
Lung Cancer; 2018 Oct; 124():233-240. PubMed ID: 30268467
[TBL] [Abstract][Full Text] [Related]
17. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
[TBL] [Abstract][Full Text] [Related]
18. A pharmacist-led medicines review intervention in community-dwelling Māori older adults- a feasibility study protocol.
Hikaka J; Hughes C; Jones R; Connolly MJ; Martini N
Res Social Adm Pharm; 2020 Sep; 16(9):1264-1271. PubMed ID: 31813763
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
[TBL] [Abstract][Full Text] [Related]
20. Patient navigation to promote lung cancer screening in a community health center for people experiencing homelessness: Protocol for a pragmatic randomized controlled trial.
Baggett TP; Barbosa Teixeira J; Rodriguez EC; Anandakugan N; Sporn N; Chang Y; Percac-Lima S; Park ER; Rigotti NA
Contemp Clin Trials; 2022 Feb; 113():106666. PubMed ID: 34971796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
